Stoco SA has been acquired by Meyco Holding AG
The owners of Stoco SA, a supplier to the Swiss watch industry, have sold their 91.7% stake to Mayco Holding AG. The financial terms of this transaction have not been disclosed.
Stoco SA designs and builds precision systems for the assembly of watch movements and offers contract services related to the conditioning of watch movement parts. Clients are mostly large and renowned Swiss watchmaking companies. The owners decided to sell their shares to an industrial buyer, who would secure the continuity of the company at its present location and support its further development together with the existing management.
Meyco Holding AG owns numerous companies supplying the watch industry, including Lécureux SA, which is a supplier of precision assembly machinery to the watchmaking and medical technology industries.
Oaklins' team in Switzerland advised the owners of Stocco SA on the sale of their shares.
Talk to the deal team
Related deals
Sunlight Group has acquired a 51% stake in Lehmann Marine GmbH
Through its acquisition of a 51% stake in Lehmann Marine GmbH, Sunlight Group continues to strengthen its position in the growing energy solutions market, while expanding its portfolio of innovative technologies. With over 30 years of expertise in producing lead-acid and lithium-ion batteries, Sunlight Group has established itself as a leader in advanced battery technology.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more